'Mad Money' Lightning Round: Stick With Baidu

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks callers offered up during the Mad Money Lightning Round Friday evening:

Baidu (BIDU): "It did report a great quarter and it's the only Chinese stock that I'm recommending. I'd stick with it."

Genomic Health (GHDX): "I think you need to give this one some room. I think it can go still lower. Sorry."

Molycorp (MCP): "No, I'm a balance sheet guy and I like earnings and dividends. I just don't see any of that from them."

Epizyme (EPZM): "This is not what people want right now. I'd let it come in more since they don't have earnings."

Brunswick (BC): "They lowered their numbers, then hit those numbers. I like the fact they lowered the bar."

SandRidge Energy (SD): "I like the company. I like the CEO. SD is for me."

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.

If you liked this article you might like

A Cautious Strategy to Go Long Baidu ADRs

A Cautious Strategy to Go Long Baidu ADRs

Bitcoin Today: Price Breaks Below Key $9,000 Level, India Cracks Down

Bitcoin Today: Price Breaks Below Key $9,000 Level, India Cracks Down

AMD's Results and Guidance Provide Reasons for Cautious Optimism

AMD's Results and Guidance Provide Reasons for Cautious Optimism

What Was Behind Intel's Very Solid Quarter

What Was Behind Intel's Very Solid Quarter

9 Top Global Stock and ETF Picks for 2018

9 Top Global Stock and ETF Picks for 2018